Cargando…
The Survival Advantage of Lobectomy over Wedge Resection Lessens as Health-Related Life Expectancy Decreases
INTRODUCTION: Patients with early-stage NSCLC typically must choose between a surgery with superior local control (lobectomy) or one that preserves lung parenchyma (wedge). Recognizing that many patients with cancer have competing mortality risks unrelated to cancer, we investigated whether an estab...
Autores principales: | Salazar, Michelle C., Canavan, Maureen E., Walters, Samantha L., Chilakamarry, Sitaram, Ermer, Theresa, Blasberg, Justin D., Yu, James B., Gross, Cary P., Boffa, Daniel J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474228/ https://www.ncbi.nlm.nih.gov/pubmed/34590002 http://dx.doi.org/10.1016/j.jtocrr.2021.100143 |
Ejemplares similares
-
Evaluation of gastroesophageal reflux disease and hiatal hernia as risk factors for lobectomy complications
por: Kaminski, Michael F., et al.
Publicado: (2022) -
Assessment of a collaborative treatment model for trimodal management of esophageal cancer
por: Udelsman, Brooks V., et al.
Publicado: (2023) -
Chemoradiation as a nonsurgical treatment option for early-stage esophageal cancers: a retrospective cohort study
por: Pathak, Ranjan, et al.
Publicado: (2021) -
Immunotherapy After Chemotherapy and Radiation for Clinical Stage III Lung Cancer
por: Pichert, Matthew D., et al.
Publicado: (2022) -
Association of Insurance Status and Extent of Organ Involvement With Survival Among Patients With Stage IV Cancer
por: Zhan, Peter L., et al.
Publicado: (2022)